193 related articles for article (PubMed ID: 21931695)
1. Association of inherited variation in Toll-like receptor genes with malignant melanoma susceptibility and survival.
Gast A; Bermejo JL; Claus R; Brandt A; Weires M; Weber A; Plass C; Sucker A; Hemminki K; Schadendorf D; Kumar R
PLoS One; 2011; 6(9):e24370. PubMed ID: 21931695
[TBL] [Abstract][Full Text] [Related]
2. Genetic variation in TLR pathway and the risk of pulmonary tuberculosis in a Moldavian population.
Varzari A; Deyneko IV; Vladei I; Grallert H; Schieck M; Tudor E; Illig T
Infect Genet Evol; 2019 Mar; 68():84-90. PubMed ID: 30529560
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in toll-like receptor 3 and 4 genes as prognostic and outcome biomarkers in melanoma patients.
Ostojic N; Radevic T; Kandolf Sekulovic L; Djordjevic B; Jaukovic L; Stepic N; Supic G
Melanoma Res; 2022 Oct; 32(5):309-317. PubMed ID: 35855659
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk.
Sun J; Wiklund F; Zheng SL; Chang B; Bälter K; Li L; Johansson JE; Li G; Adami HO; Liu W; Tolin A; Turner AR; Meyers DA; Isaacs WB; Xu J; Grönberg H
J Natl Cancer Inst; 2005 Apr; 97(7):525-32. PubMed ID: 15812078
[TBL] [Abstract][Full Text] [Related]
5. Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.
Abida O; Bahloul E; Elloumi N; Toumi A; Tahri S; Ben Jmaa M; Fakhfakh R; Mahfoudh N; Turki H; Masmoudi H
Biomed Res Int; 2020; 2020():6541761. PubMed ID: 33204706
[TBL] [Abstract][Full Text] [Related]
6. Association of TLR2 and TLR4 non-missense single nucleotide polymorphisms with type 2 diabetes risk in a southern Chinese population: a case-control study.
Huang WH; Nie LH; Zhang LJ; Jing LP; Dong F; Wang M; Zhang N; Liu Y; Zhang BH; Chen C; Lin HS; Wei XC; Yang G; Jing CX
Genet Mol Res; 2015 Jul; 14(3):8694-705. PubMed ID: 26345801
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation.
Bochud PY; Chien JW; Marr KA; Leisenring WM; Upton A; Janer M; Rodrigues SD; Li S; Hansen JA; Zhao LP; Aderem A; Boeckh M
N Engl J Med; 2008 Oct; 359(17):1766-77. PubMed ID: 18946062
[TBL] [Abstract][Full Text] [Related]
8. TLR2, TLR3, TLR4 and CD14 gene polymorphisms associated with oral lichen planus risk.
Stanimirovic D; Zeljic K; Jankovic L; Magic M; Hadzi-Mihajlovic M; Magic Z
Eur J Oral Sci; 2013 Oct; 121(5):421-6. PubMed ID: 24028589
[TBL] [Abstract][Full Text] [Related]
9. An association between single nucleotide polymorphisms within TLR and TREM-1 genes and infective endocarditis.
Golovkin AS; Ponasenko AV; Yuzhalin AE; Salakhov RR; Khutornaya MV; Kutikhin AG; Rutkovskaya NV; Savostyanova YY; Barbarash LS
Cytokine; 2015 Jan; 71(1):16-21. PubMed ID: 25213166
[TBL] [Abstract][Full Text] [Related]
10. TLR2, TLR4 and CD86 gene polymorphisms in recurrent aphthous stomatitis.
Karasneh J; Bani-Hani M; Alkhateeb A; Hassan A; Alzoubi F; Thornhill M
J Oral Pathol Med; 2015 Nov; 44(10):857-63. PubMed ID: 25482673
[TBL] [Abstract][Full Text] [Related]
11. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
[TBL] [Abstract][Full Text] [Related]
12. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in a case-control study with bladder cancer susceptibility in a North Indian population.
Singh V; Srivastava N; Kapoor R; Mittal RD
Arch Med Res; 2013 Jan; 44(1):54-61. PubMed ID: 23142523
[TBL] [Abstract][Full Text] [Related]
13. Screening toll-like receptor markers to predict latent tuberculosis infection and subsequent tuberculosis disease in a Chinese population.
Wu L; Hu Y; Li D; Jiang W; Xu B
BMC Med Genet; 2015 Apr; 16():19. PubMed ID: 25928077
[TBL] [Abstract][Full Text] [Related]
14. Impact of Toll-like Receptors 2(TLR2) and TLR 4 Gene Variations on HCV Susceptibility, Response to Treatment and Development of Hepatocellular Carcinoma in Cirrhotic HCV Patients.
Neamatallah M; El-Bendary M; Elalfy H; Besheer T; El-Maksoud MA; Elhammady D; Abed S; Elegezy M; Kandeel L; Eldeib D; Mousa N; Abd El-Hafeez M; El-Gilany AH; Esmat G
Immunol Invest; 2020 May; 49(4):462-476. PubMed ID: 31615295
[No Abstract] [Full Text] [Related]
15. Correlation between TLR2, TLR3, TLR4, and TLR9 polymorphisms and susceptibility to and prognosis of severe hepatitis among the newborns.
Qiu X; Dong Y; Cao Y; Luo Y
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28703296
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor polymorphism in host immune response to infectious diseases: A review.
Mukherjee S; Huda S; Sinha Babu SP
Scand J Immunol; 2019 Jul; 90(1):e12771. PubMed ID: 31054156
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
[TBL] [Abstract][Full Text] [Related]
18. Association of Toll-Like Receptor Polymorphisms With Nasal Polyposis.
Kesici GG; Kargın Kaytez S; Özdaş T; Özdaş S
Ear Nose Throat J; 2021 Jan; 100(1):NP26-NP32. PubMed ID: 31304782
[TBL] [Abstract][Full Text] [Related]
19. Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients.
Bronkhorst MW; Boyé ND; Lomax MA; Vossen RH; Bakker J; Patka P; Van Lieshout EM
J Trauma Acute Care Surg; 2013 Mar; 74(3):862-70. PubMed ID: 23425749
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptor (TLR) and nucleosome-binding oligomerization domain (NOD) gene polymorphisms and endometrial cancer risk.
Ashton KA; Proietto A; Otton G; Symonds I; McEvoy M; Attia J; Scott RJ
BMC Cancer; 2010 Jul; 10():382. PubMed ID: 20646321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
